Baljinder Bhullar - 15 May 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 May 2025, 16:44:04 UTC
Prior SEC filing
16 Jan 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/Baljinder Bhullar/

Key filing fact

Baljinder Bhullar filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 16 May 2025.

Key facts

  • This page summarizes Baljinder Bhullar's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
  • 1 reported transaction and 1 derivative row are listed below.
  • Accepted by SEC: 16 May 2025, 16:44.

Change

  • Previous filing in this sequence was filed on 16 Jan 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001401225 Primary reporting owner

Bhullar Baljinder

Relationship
Director
Address
704 ALEXANDER STREET, VANCOUVER, BRITISH COLUMBIA, CANADA
Signature
/Baljinder Bhullar/
Signature date
16 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
13,000
Date
15 May 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LEXX transaction Derivative

Stock Options

Award

Transaction value
$0
Shares
+11,000
Change %
Price
$0.000000
Shares after
11,000
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
11,000
Exercise price
$1.04
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .